March 06, 2015
3 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Drop to treat presbyopia in phase 2 trials
ATLANTA – Liquid Vision from Presbyopia Therapies is being investigated in phase 2 clinical trials as a topical, reversible, short-term treatment for presbyopia, reported Terry Kim, MD, here at SECO.
Different from pilocarpine, the drop acts only on the sphincter muscle, not the ciliary muscle, thereby creating miosis without accommodative effect.
Some patients have shown improvement of up to six lines of near vision, with good distance vision, he said.